We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Avnet
AVT
$7.61B
| $483K | ﹤0.01% |
9,581
-183
| -2% | -$8.06K |
|
1377
Array Technologies
ARRY
$647M
| $482K | ﹤0.01% |
+21,347
| New | +$457K |
|
1378
Invitation Homes
INVH
$16.1B
| $482K | ﹤0.01% |
14,020
+10,494
| +298% | +$351K |
|
1379
GATX Corp
GATX
$6.27B
| $479K | ﹤0.01% |
3,719
+61
| +2% | +$7.14K |
|
1380
Oportun Financial
OPRT
$359M
| $478K | ﹤0.01% |
80,000
-100,000
| -56% | -$491K |
|
1381
Carter's
CRI
$1.07B
| $472K | ﹤0.01% |
6,496
+720
| +12% | +$48.6K |
|
1382
Spire
SR
$4.72B
| $470K | ﹤0.01% |
7,410
+1,913
| +35% | +$128K |
|
1383
Northrop Grumman
NOC
$75.4B
| $469K | ﹤0.01% |
1,029
-1,113
| -52% | -$505K |
|
1384
Coda Octopus Group
CODA
$121M
| $469K | ﹤0.01% |
57,105
-3,426
| -6% | -$29.8K |
|
1385
Kemper
KMPR
$1.61B
| $468K | ﹤0.01% |
9,706
+3,063
| +46% | +$148K |
|
|
LGTY
1386
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $468K | ﹤0.01% |
44,565
-2,662
| -6% | -$32.1K |
|
1387
FirstCash
FCFS
$9.53B
| $464K | ﹤0.01% |
4,975
-285
| -5% | -$27.8K |
|
|
MRSN
1388
DELISTED
Mersana Therapeutics
MRSN
| $463K | ﹤0.01% |
+5,626
| New | +$823K |
|
1389
Valley National Bancorp
VLY
$7.48B
| $459K | ﹤0.01% |
59,234
+465
| +0.8% | +$3.7K |
|
|
CMBM
1390
DELISTED
Cambium Networks
CMBM
| $458K | ﹤0.01% |
30,061
+30,006
| +54,556% | +$465K |
|
1391
C3.ai
AI
$1.7B
| $455K | ﹤0.01% |
12,500
-40,441
| -76% | -$1.14M |
|
1392
CSX Corp
CSX
$88.7B
| $454K | ﹤0.01% |
13,324
-27,802
| -68% | -$879K |
|
1393
Phreesia
PHR
$636M
| $454K | ﹤0.01% |
14,643
-93,857
| -87% | -$2.94M |
|
|
REVG
1394
DELISTED
REV Group
REVG
| $453K | ﹤0.01% |
+34,146
| New | +$390K |
|
|
AMED
1395
DELISTED
Amedisys
AMED
| $450K | ﹤0.01% |
4,926
-34,758
| -88% | -$2.85M |
|
1396
NorthWestern Energy
NWE
$4.22B
| $450K | ﹤0.01% |
7,923
-1,032
| -12% | -$60.3K |
|
1397
Norwegian Cruise Line
NCLH
$6.67B
| $449K | ﹤0.01% |
20,647
+17,230
| +504% | +$264K |
|
1398
Ormat Technologies
ORA
$5.65B
| $447K | ﹤0.01% |
5,553
-212
| -4% | -$18K |
|
|
OLPX
1399
DELISTED
Olaplex Holdings
OLPX
| $446K | ﹤0.01% |
+120,000
| New | +$440K |
|
1400
Pacific Biosciences
PACB
$417M
| $446K | ﹤0.01% |
33,537
+33,536
| +3,353,600% | +$408K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.